Merrimack Pharmaceuticals Inc. News
Verastem Shares Jump On Cancer Drug Data - Biotech Movers
The Boston firm unveils positive results from its Phase 3 study of duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.
Otonomy Shares Rebound After Wednesday's Drop- Biotech Movers
Otonomy shares rose in premarket trading on Aug. 31 after plunging Wednesday on the heels of disappointing data in a Phase 3 study of Otividex in patients with Meniere's disease.
Biotech Movers: Array Shares Rise on Bristol-Myers Collaboration
Array BioPharma, Advaxis, Merrimack Pharmaceuticals and Insys Therapeutics were among the biotech stock movers in premarket trading on Tuesday.
Immunomedics, Seattle Genetics lead biotech movers on deal news
The companies inked a $250 million deal on Friday that could be worth up to $2 billion, thanks to milestone payments.
Here are the the biotech stocks moving ahead of the opening bell
McKesson, Bristol-Myers and Varian were having a busy morning.
Closing Bell: Alibaba's Ma Meets With Trump; Nasdaq Hits Record
The Dow Jones Industrial Average's road to 20,000 has another detour as a selloff in crude spooks the energy sector.
The Monday sights, sounds and biotech buzz from the J.P. Morgan Healthcare Conference
The $5.2 billion takeout of Ariad Pharma was the biggest news from the closely followed healthcare conference.
Starbucks and Pepsi Make Wolfe List of Top Dividend Stocks
The S&P 500 Dividend Aristocrats index has slipped 6% year to date, compared with a 17% drop for the S&P 500.
Vietnamese Tesla Rival Sets Sail for the U.S. Market
VinFast is shipping 999 of its electric vehicles to California as the Vietnamese company looks for a place in the U.S. market.